French Innovative Leukemia Organization

Adjunction of a Fish Oil Emulsion to Cytarabine and Daunorubicin ...

the Famyly Pilot Study from the French Innovative Leukemia Organization (FILO). Program: Oral and Poster Abstracts Session: 613. Acute ...

Ibrutinib Plus Venetoclax Induces Lower MRD Rate Vs FCR in ...

The randomized phase 2 ERADIC trial, a French Innovative Leukemia Organization (FILO) trial presented by co-principal investigator Anne ...

Mutational and cytogenetic analyses of 188 CLL patients with ...

This retrospective study, carried out by the French Innovative Leukemia Organization, included 188 tri12 patients with comprehensive information on ...

Intensified Rituimab Prephase Before FCR in Untreated B-CLL

Haematologica 2018 - Increased rituximab exposure does not improve response and outcome of CLL patients after FCR. A French Innovative Leukemia Organization ( ...

Leukemia & Lymphoma Society | Blood Cancer Leaders | LLS

The Leukemia & Lymphoma Society has been the largest nonprofit funder of blood cancer research since 1949. Visit us to learn more about how you can help.

Long‐term results of Waldenström macroglobulinaemia treatment by ...

3 This strategy was applied by the French Innovative Leukemia Organization. (FILO) from January 2013 to December 2017 for 69 treatment- naïve ...

French Observational Study of Patients with Chronic Lymphocytic ...

... Leukemia or Small Lymphocytic Lymphoma in Real-World Settings (FOLLOW). F. French Innovative Leukemia Organisation. Status. Enrolling. Conditions. CLL/SLL.

Final Analysis of CLL6 Residuum Study of the Australian Leukaemia ...

... Lymphoma Group (ALLG) and the French Innovative Leukemia Organization (FILO) ... leukemia (CLL) patients. Lenalidomide (LEN) has antiproliferative and ...

Long‐term results of Waldenström macroglobulinaemia treatment by ...

... French Innovative Leukemia Organization (FILO) | The bendamustine–rituximab (BR) schedule is an efficient first‐line therapy in Waldenström ...

Biographies of the editorial board of Hématologie - JLE

... French Innovative Leukemia Organization leucémies aiguës myéloïdes (FILO LAM). ... France lymphoma espoir, ligue contre le cancer, Waldenström France. He ...

Clinical and biological characteristics of leukemia cutis in chronic ...

Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization ...

Recommendations for the Management of Patients with Hairy-Cell ...

... Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group. https://doi.org/10.3390/cancers16122185 ·.

preliminary results of MRD-guided ibrutinib plus venetoclax vs FCR

... (French Innovative Leukemia Organization) group, which compares a ... leukemia (CLL). This interview was recorded at the biennial ...

News - Acute Leukemia French Association

• Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL), • French Innovative Leukemia Organization, (FILO), • Groupe Francophone des ...

GCO, A French network of ten cooperative groups conducting ...

SFCE: French Society for the Fight against Cancer and Leukemia in Children and Adolescents ... Innovative Leukemia Organization (FILO), FIM (French ...

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL)

on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group ... INSERMU1138, UPMC Paris ...

French foundation for cancer research - Donate Cancer research ...

Institut Curie, the leading French cancer treatment and research center · Cancer types · Excellence, from research to care · Let's work together · The Institut ...

Diagnosis and Treatment of Chronic Lymphocytic Leukemia

The recommendations of the French Innovative Leukemia Organization (FILO‐CLL) group presented here are intended to provide practical recommendations for ...

Diversity of TP53 Mutations in CLL

tions from the French Innovative. Leukemia Organization (FILO) Group. Myriam ... Design: We have collected 450 TP53 variants from 340 CLL patients within the FILO ...

Lomustine is beneficial to older AML with ELN2017 adverse risk ...

Bioinformatic Department, Claudius Regaud Institute, Institut Universitaire du Cancer de Toulouse Oncopôle, Toulouse, France. ... Leukemia Group. Leukemia, (3): ...